
Vocefta 250mg Injection
Marketer
Vokin Biotech Pvt Ltd
Salt Composition
Ceftazidime (250mg)
Overview Vocefta 250mg Injection
Ceftobiprole 250mg injection combats bacterial infections throughout the body. Its efficacy extends to infections affecting the brain, lungs, ears, urinary tract, skin, soft tissues, bones and joints, bloodstream, and heart, and it's also utilized as a surgical prophylaxis. This antibiotic inhibits bacterial proliferation, alleviating symptoms and resolving the underlying infection. Administered intravenously or via intramuscular injection by a medical professional, dosage is determined individually. Consistent, evenly-spaced dosing, as directed, is crucial; incomplete treatment may result in relapse or infection exacerbation. Commonly reported side effects include skin rashes and diarrhea; localized injection site redness or discomfort may occur temporarily. These are usually mild, but persistent or bothersome effects warrant medical attention. Prior to use, disclose any antibiotic allergies, liver or kidney issues, and all other medications to your physician. Pregnant or breastfeeding individuals require prior medical consultation.
Primary Ingredients of Vocefta 250mg Injection
There is no text provided to rephrase.
Uses of Vocefta 250mg Injection
Infections caused by bacteria
Major Benefits of Vocefta 250mg Injection:
Administering this medication will be handled by your physician or their qualified nurse. Self-medication is strongly discouraged.
Common Side effects of Vocefta 250mg Injection:
- Rash
- Allergic reaction
- Injection site reaction
- Diarrhea
How to use Vocefta 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Vocefta 250mg Injection works:
Vocefta, a 250mg injectable antibiotic, eradicates bacteria by disrupting their cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vocefta 250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Vocefta, 250mg, is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Vocefta (250mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant. However, prolonged administration of Vocefta 250mg Injection should be avoided due to the potential for side effects including skin rash and diarrhea.
DrivingUNSAFE
The injection Vocefta 250mg can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
The use of Vocefta 250mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Vocefta 250mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with significant hepatic impairment should use Vocefta 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vocefta 250mg Injection :
Omit a Vocefta 250mg Injection dose? Seek your physician's advice.
Facts to Know About Vocefta 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-spectrum cephalosporins (generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Third-generation Cephalosporins |
